however, these drugs have been misused Currently available data do not suggest that rhGH treatment should be used to promote longevity Lack of GH action in mouse models is associated with extended longevity, but the mechanism underlying the increased lifespan has yet to be established Given the effects of reduced GH/IGF-1 signalling on lifespan in rodents, decreased GH action might be beneficial for humans, but clinical trials are needed to assess long-term outcome of GH/IGF-1 inhibition This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
FDA approves new medication for chronic weight management U.S
PlexusDx simplifies this process by partnering exclusively with credentialed 503A compounders, allowing you to focus on clinical outcomes rather than pharmacy vetting
Featuring Opitac glutathione delivered through an advanced liposomal system, this formula enhances absorption and bioavailability for meaningful antioxidant support
Whilst clinical trials primarily document gastrointestinal adverse effects, some patients report experiencing body aches, muscle discomfort, or joint pain during treatment
